New Enzyme Discovery Sheds Light on Severe Respiratory Infections

Researchers identify OLAH as a key factor in predicting disease severity for flu, COVID-19, and other viral infections.

OLAH enzyme linked to severe outcomes in multiple respiratory infections, including influenza and COVID-19.
High OLAH expression correlates with fatal disease progression, while low levels are found in mild cases.
Mouse models show reduced severity of viral infections when OLAH is absent.
Potential for OLAH to serve as a biomarker for early risk assessment and personalized treatment strategies.
Ongoing research aims to develop OLAH-based diagnostic methods to improve patient prognosis.